PCA
AXNX icon

Prospect Capital Advisors’s Axonics, Inc. Common Stock AXNX Stock Holding History

Prospect Capital Advisors’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-51,250
Closed -$3.34M – 34
2021
Q3 		$3.34M Buy
+51,250
New +$3.5M 1.1% 26

Other funds holding AXNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Credit Suisse
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Prospect Capital Advisors's AXNX Position: Q4 2021 in Review

Prospect Capital Advisors sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2021, closing a stake of 51,250 shares — an estimated $3.34M sold.

Prospect Capital Advisors first reported a position in AXNX in Q3 2021 and held it in 1 quarter. The position peaked at $3.34M in Q3 2021. 180 funds tracked by Wall St. Rank hold AXNX as of Q4 2021.

  • Prospect Capital Advisors reported no remaining Axonics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Prospect Capital Advisors sold 51,250 Axonics, Inc. Common Stock shares in Q4 2021, an estimated $3.34M.
  • Prospect Capital Advisors first reported a position in Axonics, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Prospect Capital Advisors's Axonics, Inc. Common Stock position peaked at $3.34M in Q3 2021.
  • 180 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2021.

Based on Prospect Capital Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.